In conclusion, the present study identified alterations of small effect size in blood levels of short-chain ACs related to the presence and severity of depression, especially of clinical profiles expressing symptoms reflecting altered energy homeostasis
Identification of potential antimicrobial targets of Pseudomonas aeruginosa biofilms through a novel screening approach
Preclinical studies suggest that GLP1 receptor activation may blunt dopamine release in response to alcohol, thereby reducing the reinforcing effects that contribute to craving and consumption
Based on publicly available information, Gala GLP-1 displays meaningful trust signals: a LegitScript verification seal (a third-party compliance monitoring service, not a government regulator), HIPAA compliance protocols referenced in the privacy policy, transparent compounding disclosure on the homepage itself, a registered business entity (AI Coaching, Inc.), and published contact information
Investor news release